P28335 (5HT2C_HUMAN) Homo sapiens (Human)
5-hydroxytryptamine receptor 2C UniProtKBInterProSTRINGInteractive Modelling
458 aa; Sequence (Fasta) ; (Isoform 2)
Available Structures
7 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Cryo-EM structure of the 5HT2C receptor (INI isoform) bound to psilocin |
Heteromer P59768; P62873; | 100.0 | 1×91Q; 1×CLR; | |||
| Cryo-EM structure of the 5HT2C receptor (VGV isoform) bound to lorcaserin |
Heteromer P59768; P62873; | 98.86 | 1×T4U; 2×CLR; | |||
| Cryo-EM structure of the 5HT2C receptor (VSV isoform) bound to lorcaserin |
Heteromer P59768; P62873; | 98.86 | 1×T4U; 1×CLR; | |||
| Cryo-EM structure of the 5HT2C receptor (INI isoform) bound to lorcaserin |
Heteromer P59768; P62873; | 100.0 | 1×T4U; 1×CLR; | |||
| Crystal structure of 5-HT2C in complex with ergotamine | monomer | 100.0 | 1×ERM; 1×OLC; | |||
| Crystal structure of 5-HT2C in complex with ritanserin | monomer | 100 | 1×E2J; 6×OLC; 1×PEG; 2×OLA; | |||
| Crystal structure of an inverse agonist antipsychotic drug derivative-bound 5-HT2C | monomer | 100.0 | 1×A1L10; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6bqh.1.A | monomer | 0.65 | 1×E2J; 4×OLC; 2×OLA; | 85.01 | ||
1 SWISS-MODEL model built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 4nc3.1.A | monomer | 0.67 | 51.43 | |||